2019 Vol.37, N°3 - Suppl.118 - Table of contents

Sjögren’s syndrome 2019

Second Annual Supplement on Sjögren’s syndrome

Guest Editors: M. Bombardieri, S. De Vita, T. Dörner, M. Ramos-Casals, A.G. Tzioufas

One year in review

CER12551
2019,37,3,Suppl.118
Pg. 0003-0015

Free to view

One year in review 2019: Sjögren’s syndrome
G. Cafaro, C. Croia, O.D. Argyropoulou, M.C. Leone, M. Orlandi, F. Finamore, A. Cecchettini, F. Ferro, C. Baldini, E. Bartoloni

Editorials

CER12472
2019,37,3,Suppl.118
Pg. 0016-0018

Free to view

The necessity of novel biomarkers in primary Sjögren’s syndrome
A.G. Tzioufas, A.V. Goules

CER12398
2019,37,3,Suppl.118
Pg. 0019-0023

Free to view

The Big Data Sjögren Consortium: a project for a new data science era
N. Acar-Denizli, B. Kostov, M. Ramos-Casals
on behalf of the Sjögren Big Data Consortium

CER12442
2019,37,3,Suppl.118
Pg. 0024-0026

Free to view

Current limitations and ongoing initiatives to evaluate the activity, damage and outcome of primary Sjögren’s syndrome
S. De Vita, A. Zabotti, S. Gandolfo

CER12559
2019,37,3,Suppl.118
Pg. 0027-0028

Free to view

Variation in primary Sjögren's syndrome care among European countries
C. Seghieri, E. Lupi, T.P. Exarchos, F. Ferro, A.G. Tzioufas, C. Baldini

Aetiopathogenesis

CER11454
2019,37,3,Suppl.118
Pg. 0029-0035

Free to view

α-enolase is an antigenic target in primary Sjögren’s syndrome
E. Olivares-Martínez, D.F. Hernández-Ramírez, C.A. Núñez-Álvarez, L. Llorente, G. Hernandez-Molina

CER11534
2019,37,3,Suppl.118
Pg. 0036-0041

Free to view

Angiogenic T cells in primary Sjögren’s syndrome: a double-edged sword?
A. Alunno, L. Ibba-Manneschi, O. Bistoni, S. Cipriani, F. Topini, R. Gerli, M. Manetti

CER11811
2019,37,3,Suppl.118
Pg. 0042-0048

Free to view

Presence of intraepithelial B-lymphocytes is associated with the formation of lymphoepithelial lesions in salivary glands of primary Sjögren’s syndrome patients
M.S. Van Ginkel, E.A. Haacke, H. Bootsma, S. Arends, J.F. Van Nimwegen, G.M. Verstappen, F.K. Spijkervet, A. Vissink, B. Van Der Vegt, F.G. Kroese

CER11677
2019,37,3,Suppl.118
Pg. 0049-0054

Free to view

Differential expression of miR-17-92 cluster among varying histological stages of minor salivary gland in patients with primary Sjögren’s syndrome
T. Yan, J. Shen, J. Chen, M. Zhao, H. Guo, Y. Wang

CER12383
2019,37,3,Suppl.118
Pg. 0055-0064

Free to view

Thymic stromal lymphopoietin expression from benign lymphoproliferation to malignant B-cell lymphoma in primary Sjögren’s syndrome
S. Gandolfo, M. Bulfoni, C. Fabro, S. Russi, D. Sansonno, C. Di Loreto, D. Cesselli, S. De Vita

Clinical aspects

CER11446
2019,37,3,Suppl.118
Pg. 0065-0069

Free to view

Prevalence of sicca syndrome in the Peruvian population
L.A. Moreno-Quispe, I.V.N. Velarde-Grados, M. Guzmán-Avalos, L. De Arriba, R.M. López-Pintor

CER11455
2019,37,3,Suppl.118
Pg. 0070-0077

Free to view

Evaluation of salivary and plasma microRNA expression in patients with Sjögren’s syndrome, and correlations with clinical and ultrasonographic outcomes
R. Talotta, V. Mercurio, S. Bongiovanni, C. Vittori, L. Boccassini, F. Rigamonti, A. Batticciotto, F. Atzeni, D. Trabattoni, P. Sarzi-Puttini, M. Biasin

CER11729
2019,37,3,Suppl.118
Pg. 0078-0082

Free to view

A two-phase cohort study of the sleep phenotype within primary Sjögren’s syndrome and its clinical correlates
I. Lewis, K.L. Hackett, W.-F. Ng, J. Ellis, J.L. Newton

CER12121
2019,37,3,Suppl.118
Pg. 0083-0089

Free to view

Trends in employment and hospitalisation in patients with Sjögren's syndrome 1996-2016: results from the German National database
J. Callhoff, K. Thiele, T. Dörner, A. Zink, J.G. Richter, J. Henes, K. Albrecht

CER12250
2019,37,3,Suppl.118
Pg. 0090-0096

Free to view

Enhancing medical data quality through data curation: a case study in primary Sjögren’s syndrome
V.C. Pezoulas, K.D. Kourou, F. Kalatzis, T.P. Exarchos, A.I. Venetsanopoulou, E. Zampeli, S. Gandolfo, F.N. Skopouli, S. De Vita, A.G. Tzioufas, D.I. Fotiadis

CER12343
2019,37,3,Suppl.118
Pg. 0097-0106

Free to view

Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients
S. Retamozo, N. Acar-Denizli, A. Rasmussen, I.F. Horváth, C. Baldini, R. Priori, P. Sandhya, G. Hernandez-Molina, B. Armagan, S. Praprotnik, M. Kvarnstrom, R. Gerli, A. Sebastian, R. Solans, M. Rischmueller, S.G. Pasoto, V. Valim, G. Nordmark, A. Kruize, H. Nakamura, B. Hofauer, R. Giacomelli, V. Fernandes Moça Trevisani, V. Devauchelle-Pensec, F. Atzeni, T.A. Gheita, S. Consani-Fernández, A. Szántó, K. Sivils, A. Gattamelata, D. Danda, L. Kilic, E. Bartoloni, S. Bombardieri, J. Sánchez-Guerrero, M. Wahren-Herlenius, X. Mariette, M. Ramos-Casals, P. Brito-Zerón
on behalf of the Sjögren Big Data Consortium

CER12486
2019,37,3,Suppl.118
Pg. 0107-0113

Free to view

Distinct clinical characteristics of anti-Ro/SSA-negative primary Sjögren’s syndrome: data from a nationwide cohort for Sjögren’s syndrome in Korea
Y. Park, J. Lee, J.H. Koh, Y. Sung, S. Lee, J.Y. Choe, S. Shim, J. Kim, S.R. Kwon, H. Kim, S. Chung, S.-H. Park, S. Kwok

CER12399
2019,37,3,Suppl.118
Pg. 0114-0122

Free to view

Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR)
M. Ramos-Casals, A. Maria, M.E. Suárez-Almazor, O. Lambotte, B.A. Fisher, G. Hernández-Molina, P. Guilpain, X. Pundole, A. Flores-Chávez, C. Baldini, C.O. Bingham Iii, P. Brito-Zerón, J.-E. Gottenberg, M. Kostine, T.R. Radstake, T. Schaeverbeke, H. Schulze-Koops, L. Calabrese, M.A. Khamashta, X. Mariette
on behalf of the ICIR

CER12524
2019,37,3,Suppl.118
Pg. 0123-0132

Free to view

Renal involvement in primary Sjögren’s syndrome: natural history and treatment outcome
A. Goules, D. Geetha, L.J. Arend, A.N. Baer

CER12558
2019,37,3,Suppl.118
Pg. 0133-0139

Free to view

Application of artificial neural network analysis in the evaluation of cardiovascular risk in primary Sjögren’s syndrome: a novel pathogenetic scenario?
E. Bartoloni, C. Baldini, F. Ferro, A. Alunno, F. Carubbi, G. Cafaro, S. Bombardieri, R. Gerli, E. Grossi

Diagnosis

CER12104
2019,37,3,Suppl.118
Pg. 0140-0145

Free to view

Evaluation of salivary gland ultrasonography in primary Sjögren's syndrome: does it reflect clinical activity and outcome of the disease?
N. Inanc, Y. Şahinkaya, G. Mumcu, F. Türe Özdemir, A. Paksoy, Z. Ertürk, H. Direskeneli, G.A. Bruyn

CER12487
2019,37,3,Suppl.118
Pg. 0146-0152

Free to view

Hyperechoic bands detected by salivary gland ultrasonography are related to salivary impairment in established Sjögren's syndrome
A. Zabotti, S. Zandonella Callegher, S. Gandolfo, F. Valent, I. Giovannini, E. Cavallaro, M. Lorenzon, S. De Vita

CER12363
2019,37,3,Suppl.118
Pg. 0153-0158

Free to view

Assessment of major salivary gland ultrasonography in Sjögren’s syndrome. A comparison between bedside and post-examination evaluations
D.S. Hammenfors, H. Causevic, J. Assmus, J.G. Brun, R. Jonsson, M.V. Jonsson

Treatment

CER11500
2019,37,3,Suppl.118
Pg. 0159-0166

Free to view

Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease
M. Lanzillotta, E. Della-Torre, R. Milani, E. Bozzolo, E. Bozzalla-Cassione, L. Rovati, P.G. Arcidiacono, S. Partelli, M. Falconi, F. Ciceri, L. Dagna

Reviews

CER12011
2019,37,3,Suppl.118
Pg. 0167-0174

Free to view

Present and novel biologic drugs in primary Sjögren's syndrome
S. Fasano, D.A. Isenberg

CER11919
2019,37,3,Suppl.118
Pg. 0175-0184

Free to view

Sjögren’s syndrome towards precision medicine: the challenge of harmonisation and integration of cohorts
A.V. Goules, T.P. Exarchos, V.C. Pezoulas, K.D. Kourou, A.I. Venetsanopoulou, S. De Vita, D.I. Fotiadis, A.G. Tzioufas

CER12504
2019,37,3,Suppl.118
Pg. 0185-0191

Free to view

Type I interferon signature in Sjögren’s syndrome: pathophysiological and clinical implications
N. Marketos, I. Cinoku, A. Rapti, C.P. Mavragani

CER12552
2019,37,3,Suppl.118
Pg. 0192-0198

Free to view

The kaleidoscope of neurological manifestations in primary Sjögren’s syndrome
A. Alunno, F. Carubbi, E. Bartoloni, P. Cipriani, R. Giacomelli, R. Gerli

CER12557
2019,37,3,Suppl.118
Pg. 0199-0208

Free to view

Double anti-B cell and anti-BAFF targeting for the treatment of primary Sjögren’s syndrome
S. Gandolfo, S. De Vita

CER12461
2019,37,3,Suppl.118
Pg. 0209-0216

Free to view

Animal models of Sjögren’s syndrome: an update
F. Xiao, M. Han, X. Wang, X. Gong, E. Huang, Z. Zhu, F. Zhao, Y. Zhao, Q. Jiang, L. Lu

CER12517
2019,37,3,Suppl.118
Pg. 0217-0224

Free to view

B cell depletion with rituximab in the treatment of primary Sjögren’s syndrome: what have we learnt?
S. Grigoriadou, F. Chowdhury, E. Pontarini, A. Tappuni, S.J. Bowman, M. Bombardieri

CER12375
2019,37,3,Suppl.118
Pg. 0225-0233

Free to view

Sjögren’s syndrome is not a risk factor for periodontal disease: a systematic review
F. Maarse, D.H. Jager, S. Alterch, A. Korfage, T. Forouzanfar, A. Vissink, H.S. Brand

CER12528
2019,37,3,Suppl.118
Pg. 0234-0239

Free to view

Genetics in Sjögren’s syndrome: where we are and where we go
V.M. Harris, R.H. Scofield, K.L. Sivils

CER12560
2019,37,3,Suppl.118
Pg. 0240-0248

Free to view

Salivary extracellular vesicles versus whole saliva: new perspectives for the identification of proteomic biomarkers in Sjögren’s syndrome
A. Cecchettini, F. Finamore, I. Puxeddu, F. Ferro, C. Baldini

Case Report

CER12339
2019,37,3,Suppl.118
Pg. 0249-0251

Free to view

Autoimmune epithelitis beyond the exocrine glands: an unusual case of anti-Ro/La and Scl-70 lymphocytic interstitial pneumonia
O.D. Argyropoulou, L.G. Chatzis, D. Rontogianni, A.G. Tzioufas

Letters to the Editor

CER11735
2019,37,3,Suppl.118
Pg. 0252-0253

Free to view

Are antibodies against La (SSB) no longer useful for the diagnosis of Sjögren’s syndrome?
D. Spoerl, P. Roux-Lombard

CER11741
2019,37,3,Suppl.118
Pg. 0254-0256

Free to view

Serum soluble Fas and Fas ligand (FasL) in primary Sjögren’s syndrome
F.B. Vincent, M. Bubicich, S. Downie-Doyle, F. Mackay, E.F. Morand, M. Rischmueller